Literature DB >> 26927039

An Efficient Chemical Synthesis of Scutellarein: An in Vivo Metabolite of Scutellarin.

Ze-Xi Dong1, Nian-Guang Li2, Peng-Xuan Zhang3, Ting Gu4, Wen-Yu Wu5, Zhi-Hao Shi6.   

Abstract

Scutellarein (2), which is an important in vivo metabolite of scutellarin (1), was synthesized from 3,4,5-trimethoxyphenol (3) in high yield in four steps. This strategy relies on acetylation, aldolization, cyclization and hydrolysis reactions, respectively.

Entities:  

Keywords:  efficient; metabolite; scutellarein; scutellarin; synthesis

Mesh:

Substances:

Year:  2016        PMID: 26927039      PMCID: PMC6272953          DOI: 10.3390/molecules21030263

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


1. Introduction

As a frequently-occurring disease, ischemic cerebrovascular is a serious threat to human health and it has been one of the leading causes of death and disability around the world [1]. Traditional Chinese medicines are rich sources for drug lead compound discovery as they have been used clinically for thousands years. Scutellarin (1, Figure 1), a main active ingredient extracted from Erigeron breviscapus (Vant.) Hand-Mazz., which mainly grows in Yunnan Province of China, has been wildly used to treat acute cerebral infarction and paralysis induced by cerebrovascular diseases such as hypertension, cerebral thrombosis and cerebral hemorrhage in China since 1984 [2]. Interestingly, scutellarin (1) is mainly hydrolyzed into scutellarein (2, Figure 1) in the intestine [3], and scutellarein (2) was much more easily absorbed than scutellarin (1) after oral administration of both of them in equal doses [4]. In previous studies, our research group has found that scutellarein (2) had better protective effects than scutellarin (1) against neuronal injury in a rat cerebral ischemia model [5,6].
Figure 1

Chemical structures of scutellarin (1) and scutellarein (2).

Unfortunately, scutellarein (2) is not readily available commercially, so the chemical synthesis of this metabolite has become important in recent years. We have previously synthesized scutellarein (2) from scutellarin (1) by hydrolysis with 6N HCl in 90% ethanol under reflux, however, the yield was very low (only 17%) [7]. Cui et al. [8] completed one synthetic route to scutellarein (2) from 2-hydroxy-4,5,6-trimethoxyacetophenone (4) and 4-methoxybenzoyl chloride in three steps, unfortunately, there was a by-product in this acetylation and the yield was low. Yen et al. [9] synthesized scutellarein (2) in 47% yield in five steps starting from 3,4,5-trimethoxyphenol (3) and acetic anhydride, then the obtained 3,4,5-trimethoxyphenol acetate was transformed into 1-(6-hydroxy-2,3,4-trimethoxyphenyl)ethanone (4) after Fries rearrangement. In this paper, we report an efficient chemical synthesis of scutellarein (2) from 3,4,5-trimethoxyphenol (3) and acetic acid in only four steps and with high total yield (58%).

2. Results and Discussion

As shown in Scheme 1, the starting material 3,4,5-trimethoxyphenol (3, 200 mg, 1.09 mmol) was first reacted with acetic acid (1 mL) in boron trifluoride diethyl etherate (5 mL) under a N2 atmosphere at 85 °C, to afford a high yield (92%) of the desired Friedel Crafts acylation reaction product 4. Next, compound 5 was synthesized by a base-catalyzed Claisen-Schmidt condensation reaction of 4 and 4-methoxybenzaldehyde. Fortunately, the cyclization of 5 produced the desired compound 6 in 82% yield, using iodine as the catalyst in dimethyl sulfoxide solution at 100 °C for 2 h. Finally, the demethylation of 6 with 40% HBr in the refluxing CH3COOH led to scutellarein (2) in 90% yield, for a total overall yield of 58%.
Scheme 1

The efficient chemical synthesis of scutellarein (2).

3. Experimental Section

3.1. General Information

Reagents and solvents were purchased from commercial sources and used without further purification unless otherwise specified. Air- and moisture-sensitive liquids and solutions were transferred via syringe or stainless steel cannula. Organic solutions were concentrated by rotary evaporation (BuChi R-3, Surat, India) below 45 °C at approximately 20 mm Hg. All non-aqueous reactions were carried out under anhydrous conditions using flame-dried glassware in an argon atmosphere in dry, freshly distilled solvents, unless otherwise noted. Yields refer to chromatographically and spectroscopically (1H-NMR) homogeneous materials, unless otherwise stated. Reactions were monitored by thin-layer chromatography (TLC) carried out on 0.15–0.20 mm silica gel plates (RSGF 254, Yantai, China) using UV light as the visualizing agent. The melting points (m.p.) were measured on a WRS-1B apparatus (Hangzhou, China) and are not corrected. 1H-NMR (300 MHz) and 13C-NMR spectra (75 MHz) were obtained with a Bruker AV-300 spectrometer (Karlsruhe, Germany). Chemical shifts are recorded in ppm downfield from tetramethylsilane. J values are given in Hz. Abbreviations used are s (singlet), d (doublet), t (triplet), q (quartet), b (broad) and m (multiplet).

3.2. Synthesis

1-(6-Hydroxy-2,3,4-trimethoxyphenyl)ethanone (4): To a stirring solution of 3 (10 g, 54.5 mmol) in BF3·Et2O (25 mL) was added CH3COOH (15 mL). After stirring under N2 atmosphere at 85 °C for 2.5 h, the reaction mixture was allowed to warm to room temperature. Then ice water (50 mL) was added slowly. The mixture was extracted with ethyl acetate (30 mL) three times, and the organic layer was dried over Na2SO4, filtered and concentrated to afford 4 (11.27 g, 92% yield) as a yellow solid [9]. M.p. 147–148 °C. 1H-NMR (CDCl3) δ 6.28 (s, 1H, 5-H), 4.10 (s, 3H, 2-H), 3.97 (s, 3H, 3-H), 3.77 (s, 3H, 4-H), 2.81 (s, 3H, 2′-H); 13C-NMR (CDCl3) δ 203.5 (CO), 161.9 (C(4)), 160.7 (C(6)), 155.4 (C(2)), 134.5 (C(3)), 108.1 (C(1)), 96.1 (C(5)), 61.0 (MeO-C(2,2′)), 56.4 (MeO-C(3)), 31.4 (MeO-C(4)); ESI-MS: m/z 227 [M + H]+. 1-(6-Hydroxy-2,3,4-trimethoxyphenyl)-3-(4-methoxyphenyl)prop-2-en-1-one (5): 4-Methoxybenzaldehyde (8 mL, 66 mmol, 1.5 equiv) was added to a stirring mixture of 4 (10 g, 44 mmol) and t-BuOK (12.32 g, 110 mmol, 2.5 equiv) in EtOH (150 mL). The reaction mixture was refluxed gently for 4 h at 85 °C. After being cooled down to room temperature, the reaction mixture was poured into glacial water and the pH was adjusted to 3~4. Then the mixture was filtered and dried to afford 5 (13.02 g, 86% yield) as a yellow solid [9]. M.p. 135–136 °C. 1H-NMR (CDCl3) δ 13.78 (s, 1H, 6′-OH), 7.84 (s, 2H, 2,3-H), 7.59 (d, J = 8.7 Hz, 2H, 2′′,6′′-H), 6.92 (d, J = 8.7 Hz, 2H, 3′′,5′′-H), 6.29 (s, 1H, 5′-H), 3.92 (s, 3H, 2′-H), 3.90 (s, 3H, 3′-H), 3.86 (s, 3H, 4′-H), 3.83 (s, 3H, 4′′-H); 13C-NMR (CDCl3) δ 192.3 (CO), 162.1 (C(4)), 161.0 (C(6)), 160.0 (C(4′)), 155.4 (C(2)), 143.7 (CO-C=CH), 135.5 (C(3)), 130.6 (C(2′,6′)), 127.9 (C(1′)), 124.2 (CO-C=CH), 114.8 (C(3′,5′)), 108.3 (C(1)), 96.1 (C(5)), 62.0 (MeO-C(2)), 61.4 (MeO-C(3)), 56.4 (MeO-C(4)), 55.1 (MeO-C(4′)); ESI-MS: m/z 345 [M + H]+. 5,6,7-Trimethoxy-2-(4-methoxyphenyl)-4H-chromen-4-one (6): To a solution of 5 (10 g, 29 mmol) dissolved in DMSO (40 mL) was added I2 (0.74 g) with vigorous stirring at 100 °C. After 2 h, the reaction mixture was poured into crashed ice water (30 mL). The precipitate was filtered and washed by 10% aq. Na2S2O3 soln, followed by recrystallization in EtOH to afford 6 (8.13 g, 82% yield) as a yellow solid [9]. M.p. 140–141 °C. 1H-NMR (CDCl3) δ 7.82 (d, J = 8.9 Hz, 2H, 2′,6′-H), 7.00 (d, J = 8.9 Hz, 2H, 3′,5′-H), 6.80 (s, 1H, 3-H), 6.61 (s, 1H, 8-H), 3.99 (s, 3H, 5-H), 3.98 (s, 3H, 6-H), 3.92 (s, 3H, 7-H), 3.89 (s, 3H, 4′-H); 13C-NMR (CDCl3) δ 177.3 (C(4)), 162.4 (C(2)), 161.0 (C(4′)), 157.7 (C(7)), 154.4 (C(8a)), 152.3 (C(5)), 140.1 (C(6)), 127.7 (C(2′,6′)), 123.7 (C(1′)), 114.3 (C(3′,5′)), 112.8 (C(4a)), 106.9 (C(3)), 96.3 (C(8)), 62.1 (MeO-C(5)), 61.6 (MeO-C(6)), 56.2 (MeO-C(7)), 55.4 (MeO-C(4′)); ESI-MS: m/z 343 [M + H]+. 4',5,6,7-Tetrahydroxyflavone (2): To a solution of 6 (8 g, 23.2 mmol) dissolved in CH3COOH (100 mL) was added 40% HBr (50 mL) with stirring at 120 °C for 24 h. After cooled down to the room temperature, the reaction mixture was poured into ice water (50 mL). The precipitate was filtered and washed by water and then recrystallized by EtOH to afford 2 (5.97 g, 90% yield) as a yellow solid [9]. M.p. 160–141 °C. 1H-NMR (DMSO-d6) δ 12.79 (s, 1H, 5-OH), 10.44 (s, 1H, 7-OH), 10.30 (s, 1H, 4′-OH), 8.71 (s, 1H, 6-OH), 7.90–7.93 (d, 2H, J = 8.8 Hz, 2′,6′-H), 6.90–6.93 (d, 2H, J = 8.8 Hz, 3′,5′-H), 6.78 (s, 1H, 3-H), 6.73 (s, 1H, 8-H); 13C-NMR (DMSO-d6) δ 182.3 (C(4)), 162.4 (C(2)), 161.0 (C(4′)), 153.7 (C(7)), 149.4 (C(8a)), 147.3 (C(5)), 129.1 (C(6)), 128.7 (C(2′,6′)), 121.7 (C(1′)), 116.3 (C(3′,5′)), 104.8 (C(4a)), 102.9 (C(3)), 93.3 (C(8)); ESI-MS: m/z 287 [M + H]+.

4. Conclusions

In summary, we have developed an efficient chemical synthesis of scutellarein (2) in high yield in only four steps. This strategy relies on acetylation, aldolization, cyclization and hydrolysis step, respectively. This synthetic method is effective and it has industrial application value.
  7 in total

1.  Total synthesis of scutellarin-7-O-glucuronide.

Authors:  Jian-Mei Cui; Gang Fang; Ya-Bo Duan; Qian Liu; Li-Ping Wu; Guo-Hong Zhang; Song Wu
Journal:  J Asian Nat Prod Res       Date:  2005-08       Impact factor: 1.569

Review 2.  Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury.

Authors:  S Cuzzocrea; D P Riley; A P Caputi; D Salvemini
Journal:  Pharmacol Rev       Date:  2001-03       Impact factor: 25.468

3.  Neuroprotective effects of scutellarin and scutellarein on repeatedly cerebral ischemia-reperfusion in rats.

Authors:  Hao Tang; Yuping Tang; Nianguang Li; Qianping Shi; Jianming Guo; Erxin Shang; Jin-ao Duan
Journal:  Pharmacol Biochem Behav       Date:  2014-01-11       Impact factor: 3.533

4.  Study on metabolism of scutellarin in rats by HPLC-MS and HPLC-NMR.

Authors:  Jin-Lan Zhang; Qing-Min Che; Shou-Zhuo Li; Tong-Hui Zhou
Journal:  J Asian Nat Prod Res       Date:  2003-12       Impact factor: 1.569

Review 5.  Stroke.

Authors:  Geoffrey A Donnan; Marc Fisher; Malcolm Macleod; Stephen M Davis
Journal:  Lancet       Date:  2008-05-10       Impact factor: 79.321

6.  Synthesis and bio-activity evaluation of scutellarein as a potent agent for the therapy of ischemic cerebrovascular disease.

Authors:  Li-Hua Qian; Nian-Guang Li; Yu-Ping Tang; Li Zhang; Hao Tang; Zhen-Jiang Wang; Li Liu; Shu-Lin Song; Jian-Ming Guo; An-Wei Ding
Journal:  Int J Mol Sci       Date:  2011-11-18       Impact factor: 5.923

7.  Synthesis and protective effect of scutellarein on focal cerebral ischemia/reperfusion in rats.

Authors:  Lihua Qian; Minzhe Shen; Hao Tang; Yuping Tang; Li Zhang; Yifan Fu; Qianping Shi; Nian-Guang Li
Journal:  Molecules       Date:  2012-09-06       Impact factor: 4.411

  7 in total
  2 in total

1.  Metabolic engineering of Yarrowia lipolytica for scutellarin production.

Authors:  Yina Wang; Xiaonan Liu; Bihuan Chen; Wei Liu; Zhaokuan Guo; Xiangyu Liu; Xiaoxi Zhu; Jiayu Liu; Jin Zhang; Jing Li; Lei Zhang; Yadi Gao; Guanghui Zhang; Yan Wang; M Iqbal Choudhary; Shengchao Yang; Huifeng Jiang
Journal:  Synth Syst Biotechnol       Date:  2022-06-06

2.  Scutellarin Enhances Antitumor Effects and Attenuates the Toxicity of Bleomycin in H22 Ascites Tumor-Bearing Mice.

Authors:  Juan Nie; Hong-Mei Yang; Chao-Yue Sun; Yan-Lu Liu; Jian-Yi Zhuo; Zhen-Biao Zhang; Xiao-Ping Lai; Zi-Ren Su; Yu-Cui Li
Journal:  Front Pharmacol       Date:  2018-06-14       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.